EFRIS URA Commodity Codes

Reproductive system-products of conception, percutaneous approach

85815100 Category

Reproductive system-products of conception, percutaneous approach is an EFRIS commodity class (code 85815100) under Administrative interventions or procedures, physiological systems and anatomical regions, introduction and irrigation and circulatory in Uganda Revenue Authority's e-invoicing system.

15 items in this category

  • 85815103Introduction of analgesics, hypnotics, sedatives into products of conception, percutaneous approach
    Exempt
  • 85815110Introduction of anti-inflammatory into products of conception, percutaneous approach
    Exempt
  • 85815101Introduction of destructive agent into products of conception, percutaneous approach
    Exempt
  • 85815108Introduction of electrolytic and water balance substance into products of conception, percutaneous approach
    Exempt
  • 85815115Introduction of liquid brachytherapy radioisotope into products of conception, percutaneous approach
    Exempt
  • 85815107Introduction of local anesthetic into products of conception, percutaneous approach
    Exempt
  • 85815113Introduction of monoclonal antibody into products of conception, percutaneous approach
    Exempt
  • 85815109Introduction of nutritional substance into products of conception, percutaneous approach
    Exempt
  • 85815111Introduction of other anti-infective into products of conception, percutaneous approach
    Exempt
  • 85815114Introduction of other antineoplastic into products of conception, percutaneous approach
    Exempt
  • 85815104Introduction of other diagnostic substance into products of conception, percutaneous approach
    Exempt
  • 85815102Introduction of other gas into products of conception, percutaneous approach
    Exempt
  • 85815106Introduction of other therapeutic substance into products of conception, percutaneous approach
    Exempt
  • 85815112Introduction of oxazolidinones into products of conception, percutaneous approach
    Exempt
  • 85815105Introduction of radioactive substance into products of conception, percutaneous approach
    Exempt